ATRC AtriCure Inc

Price (delayed)

$40.92

Market cap

$1.89B

P/E Ratio

35.58

Dividend/share

N/A

EPS

$1.15

Enterprise value

$1.94B

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
The company's gross profit rose by 40% YoY and by 5% QoQ
ATRC's revenue is up by 36% year-on-year and by 6% since the previous quarter
AtriCure's quick ratio has decreased by 27% YoY but it has increased by 19% QoQ
The equity has grown by 18% YoY but it has contracted by 4.3% from the previous quarter
The debt has grown by 2.4% YoY

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
46.29M
Market cap
$1.89B
Enterprise value
$1.94B
Valuations
Price to earnings (P/E)
35.58
Price to book (P/B)
4.07
Price to sales (P/S)
6.43
EV/EBIT
34.13
EV/EBITDA
28.52
EV/Sales
6.7
Earnings
Revenue
$289.63M
EBIT
$56.88M
EBITDA
$68.06M
Free cash flow
-$40.9M
Per share
EPS
$1.15
Free cash flow per share
-$0.9
Book value per share
$10.06
Revenue per share
$6.36
TBVPS
$6.77
Balance sheet
Total assets
$584.98M
Total liabilities
$122.16M
Debt
$75.32M
Equity
$462.83M
Working capital
$152.23M
Liquidity
Debt to equity
0.16
Current ratio
4.21
Quick ratio
3.21
Net debt/EBITDA
0.69
Margins
EBITDA margin
23.5%
Gross margin
74.9%
Net margin
17.9%
Operating margin
-45.9%
Efficiency
Return on assets
8.3%
Return on equity
11.4%
Return on invested capital
18.8%
Return on capital employed
10.6%
Return on sales
19.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
3.75%
1 week
12.95%
1 month
-1.02%
1 year
-47.92%
YTD
-41.15%
QTD
-37.69%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$289.63M
Gross profit
$216.92M
Operating income
-$132.96M
Net income
$51.93M
Gross margin
74.9%
Net margin
17.9%
The net margin has soared by 178% YoY but it has contracted by 2.2% from the previous quarter
The operating margin has dropped by 144% year-on-year but it has grown by 2.8% since the previous quarter
The company's gross profit rose by 40% YoY and by 5% QoQ
ATRC's revenue is up by 36% year-on-year and by 6% since the previous quarter

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
35.58
P/B
4.07
P/S
6.43
EV/EBIT
34.13
EV/EBITDA
28.52
EV/Sales
6.7
AtriCure's EPS has increased by 3.6% from the previous quarter
ATRC's price to book (P/B) is 44% lower than its last 4 quarters average of 7.3 and 27% lower than its 5-year quarterly average of 5.6
The equity has grown by 18% YoY but it has contracted by 4.3% from the previous quarter
ATRC's P/S is 47% below its last 4 quarters average of 12.1 and 13% below its 5-year quarterly average of 7.4
ATRC's revenue is up by 36% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is AtriCure business performance
AtriCure's ROS has soared by 196% YoY but it has decreased by 3% from the previous quarter
The ROE has soared by 196% YoY
AtriCure's return on assets has increased by 9% QoQ

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
The total liabilities has dropped by 60% year-on-year and by 7% since the previous quarter
AtriCure's quick ratio has decreased by 27% YoY but it has increased by 19% QoQ
The debt is 84% less than the equity
The equity has grown by 18% YoY but it has contracted by 4.3% from the previous quarter
The debt to equity has declined by 16% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.